Bleichroeder LP

13F Holdings History for Evoke Pharma, Inc. - Common Shares (EVOK)

Symbol: EVOK on Nasdaq
Investment type: Equity / Common Shares
Latest Disclosed Ownership: 158K shares
Security Ownership: 9.99%

Shares, Excluding Options vs Price

Value, Excluding Options

Bleichroeder LP ownership in Evoke Pharma, Inc. Common Shares (EVOK)

2025-03-24 - Bleichroeder LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 158K shares of Evoke Pharma, Inc. Common Shares (EVOK). This represents 9.99% percent ownership of the company. In their previous filing dated 2025-03-21, Bleichroeder LP had reported owning 849K shares, indicating a decrease of -81.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Bleichroeder LP	9.99%		$63.2K	158K	-691,309	-81.4%	$0.40	13G/A	3/24/2025	24 Mar 2025 18:47:51
Bleichroeder LP	9.99%		$340K	849K			$0.40	13G/A	3/19/2025	21 Mar 2025 19:15:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024		-0.13%	$0	0	-825,000	-100%		Q3 2024
6/30/2024	0.13%		$436K	825K			$0.53	Q2 2024
3/31/2024	0.13%	+0.11%	$503K	825K	+825,000	NEW	$0.61	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.